Dr. Ryan leads NXP’s efforts to identify and create strategies for the advancement of cancer therapies and technologies designed to improve the lives of those with cancer.
Dr. Ryan is an internationally recognized genitourinary (GU) oncologist with expertise in the biology of and treatment of prostate cancer. Dr. Ryan earned a BA in Philosophy, magna cum laude, from Marquette University and MD from University of Wisconsin Medical School. He trained at the University of Wisconsin Hospital and Clinics, and at Memorial Sloan Kettering Cancer Center. As faculty at the University of California-San Francisco, he was named the Thomas Perkins Distinguished Professor in Cancer Research and was Associate Director of the Helen Diller Family Comprehensive Cancer Center. He has received research funding from the National Institutes of Health, the Department of Defense Prostate Cancer Research Program, and the Prostate Cancer Foundation.
Dr. Ryan led a substantial proportion of the development of Abiraterone, now a standard of care for prostate cancer patients worldwide, through leadership of clinical trials at Phases I, II and III which resulted in FDA approval. Dr. Ryan is a past Chair of the National Cancer Institute’s GU Steering Committee’s Prostate Cancer Task Force. From 2021 to 2024 Ryan served as the CEO of the Prostate Cancer Foundation. He serves as Medical Director of the Prostate Cancer Clinical Trials Consortium (PCCTC) and is a member of the Advanced Prostate Cancer Consensus Conference. Ryan has published over 240 articles and chapters in the world’s leading medical journals. He is the author of the book The Virility Paradox: The Vast Influence of Testosterone on Our Bodies, Minds, and the World We Live In, and the founder and Co-host of the podcast The Good News About Cancer. He is currently a member of the faculty at Memorial Sloan Kettering Cancer Center in New York and serves as the Medical Director of the PCCTC, a multi-national integrated research organization facilitating therapy and data development in prostate cancer.
.svg)